India accounts for over 20% of global production with $20 billion exports forecast by 2020

The India Brand Equity foundation ( IBEF) and the Pharmaceuticals Export Promotion Council ( PHARMEXCIL) have provided an update on the country’s generics market as the world’s pharma industry meets for its annual exposition at CPhI Worldview in Frankfurt, Germany.

Data confirms that the country’s branded generic sector accounts for a massive 98% of the marketplace – reaching a value in excess of $12 billion – with India remaining the world’s leading exporter.

Pharmexcil confidently forecast that generic exports are now growing at around 22% per year, with India accounting for around 20%-22% of the world’s production, covering more than 60,000 brands and 60 therapeutic classes.